NCT05035251 is a clinical trial in Glymphatic System, sponsored by Paracelsus Medical University.

Who is sponsoring NCT05035251?

NCT05035251 is sponsored by Paracelsus Medical University.

What condition does NCT05035251 study?

NCT05035251 studies Glymphatic System.

Is NCT05035251 still recruiting?

NCT05035251 is currently status unknown. Last updated 22 November 2023.

Last reviewed 2023-11-22 · How we verify

NCT05035251

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Glymphatic Pathway in Brain Imaging

Status unknown Last updated 22 November 2023

What this trial tests

trial in Glymphatic System in 60 participants. Status unknown.

Timeline

1 July 2020

Primary endpoint
11 November 2024

1 December 2024

Quick facts

Lead sponsor	Paracelsus Medical University
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	60
Start date	1 July 2020
Primary completion	11 November 2024
Estimated completion	1 December 2024
Sites	1 location across Germany

Conditions studied

Glymphatic System — all drugs for Glymphatic System →

Sponsor

Paracelsus Medical University

Who can join

Adults 18 to 90, any sex, with Glymphatic System. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To investigate the pathways of Gadolinium-based contrast agent (GBCA) in different brain compartments and evaluate correlations of GBCA enhancement with specific diseases.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Glymphatic System in Ocular Diseases: Evaluation of MRI Findings.
Manava P, Eckrich C, Luciani F, Schmidbauer J, et al · · 2022 · cited 5× · PMID 35772805 · DOI 10.3174/ajnr.a7552

Verify or expand the search:

Other recruiting trials for Glymphatic System

Currently open trials in the same condition.

NCT06950099 — Advanced Neuroimaging in Idiopathic Intracranial Hypertension · recruiting

Other Paracelsus Medical University trials

Trials by the same sponsor.

NCT07315334 — Assessing Functional Impairments in Patients With Chemotherapy-Induced Peripheral Neuropathy · not yet recruiting
NCT04591860 — A Prospective Randomised Multi - Center Trial on the Repair of Large Hiatal Hernias: Absorbable Mesh vs. Pledgeted Sutur · NA · not yet recruiting
NCT06056193 — The SIR-POBA Bypass Trial · NA · withdrawn
NCT06056206 — The SIR-POBA Shunt Trial · NA · withdrawn
NCT05506111 — Low Anterior Resection Syndrome After Rectum Resection for Rectal Carcinoma. · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05035251 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Paracelsus Medical University
Last refreshed: 22 November 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05035251.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing